What specific Nasdaq listing requirement is ScanTech AI non‑compliant with and how quickly can the company resolve it?

Listing deficiency – The Nasdaq letter flags ScanTech AI’s failure to meet the minimum bid‑price requirement. The company’s share price has fallen below the $1.00 threshold for the mandated 30‑day period, which triggers a non‑‑compliance breach under Nasdaq’s “Rule 555(b)(2).”

Resolution timeline – Nasdaq gives companies up to 180 calendar days after the deficiency notice to bring the price back above $1.00 for a sustained 30‑day period (or, alternatively, to request a “price‑re‑uplisting” hearing and present a plan). In practice, firms can often close the gap in 2–3 months if they execute a short‑term capitalization‑re‑structuring, share‑buy‑backs, or a forward‑looking press release that lifts market perception.

Trading implications – Until the bid‑price gap is remedied, the stock is exposed to heightened volatility and the risk of a delisting filing. Traders should treat STAI as a high‑beta, short‑to‑medium‑term risk—tight‑stop‑loss orders or a contrarian “buy‑the‑dip” position only if the company announces a concrete price‑re‑uplisting plan (e.g., a share‑repurchase or a secondary offering) that could revive the $1+ price level within the 180‑day window. If the deficiency persists beyond the deadline, the upside‑potential upside is sharply capped as the shares would move to the OTC market, dramatically reducing liquidity and institutional interest.